Concept Life Sciences has appointed Helen McKeever as program manager, and David Halverson as US head of Sales.

Helen joins Concept from RedX Pharma where she was project manager, leading a portfolio of small molecule projects from late discovery to early clinical development. She has over 29 years of experience in the contract research and pharmaceutical industry, including over 18 years leading a variety of preclinical and early clinical development programmes. 

David has over 20 years’ experience in business development, primarily in the drug discovery and pre-clinical development. Before joining Concept, David was President and COO at Protea Biosciences.

Michael Fort, executive chairman of Concept Life Sciences, said, “We are delighted to welcome Helen and David to the team, both of whom will be a great asset to the Group, strengthening our commercial and scientific leadership teams. Concept is on course for continued profitable growth of over 30% in 2018, as we work to expand and broaden our offerings in integrated drug discovery and analytical services.”